Serving people living with neurodegenerative disorders to maintain and improve their QOL through development of innovative medicine.
ML1808 is an intranasal anti-Alzheimer drug.
It suppresses not only Aβ oligomer but also tau oligomer and oxifative stress by using 2 active ingredients: rifampicin(RFP) and compound X.
アルツハイマー病発症予防点鼻薬 〜既に安全性が確認された2つの有効成分により実現へ
DEMENTIA
MISSION
TEAM